Bradda Head  Lithium exceeds targets, secures US$3 million royalty and moves closer to production. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,035.00
Bid: 4,059.00
Ask: 4,062.00
Change: -55.00 (-1.34%)
Spread: 3.00 (0.074%)
Open: 4,098.00
High: 4,120.00
Low: 4,035.00
Prev. Close: 4,090.00
CRDA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

6 Feb 2012 14:00

RNS Number : 8693W
Croda International PLC
06 February 2012
 



6 February 2012

 

Croda International Plc

 

Appointment of Chief Technology Officer

Croda International Plc, the speciality chemicals company, is pleased to announce that Keith Layden has been appointed to the Board as an executive director with immediate effect, in the new role of Chief Technology Officer.

Keith joined Croda in 1984 and for the past 7 years has been President of our Enterprise Technology and Actives businesses, where he has overseen significant growth in innovation and expansion into new product areas. Prior to this he held a number of Managing Director roles across our European business. As Chief Technology Officer, Keith will be responsible for accelerating the identification, development, licensing and acquisition of innovative technologies, the global co-ordination of Croda's R&D activities and the development of novel production processes for our major existing core product platforms.

Steve Foots, Croda's Chief Executive, commented,

"Keith's appointment to the Board is recognition of the importance the capture of external technologies is to our short and medium term growth plans. This is an exciting new role for Keith and the organisation."

Martin Flower, Croda's Chairman, commented,

 "We are delighted that Keith has joined the Croda Board in this important new role. His wealth of experience of the chemical industry and its related technologies will be of great value during the next phase of Croda's development. "

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

Enquiries:

Ben Foster, Pendomer Communications

020 3603 5221

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABXGDDCBGBGDL
Date   Source Headline
12th Mar 20192:22 pmRNSDirector/PDMR Shareholding
12th Mar 20192:21 pmRNSDirector/PDMR Shareholding
11th Mar 20192:16 pmRNSDirector/PDMR Shareholding
6th Mar 20193:53 pmRNSTransaction in Own Shares
6th Mar 201910:07 amRNSDirector/PDMR Shareholding
6th Mar 201910:07 amRNSDirector/PDMR Shareholding
6th Mar 201910:06 amRNSDirector/PDMR Shareholding
6th Mar 201910:03 amRNSDirector/PDMR Shareholding
6th Mar 201910:02 amRNSDirector/PDMR Shareholding
6th Mar 201910:01 amRNSDirector/PDMR Shareholding
6th Mar 201910:01 amRNSDirector/PDMR Shareholding
6th Mar 201910:00 amRNSDirector/PDMR Shareholding
6th Mar 20199:58 amRNSDirector/PDMR Shareholding
6th Mar 20199:57 amRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSResults for the year ended 31 December 2018
12th Feb 20194:47 pmRNSDirector/PDMR Shareholding
11th Jan 20194:21 pmRNSDirector/PDMR Shareholding
31st Dec 20187:00 amRNSAcquisition completion
17th Dec 20187:00 amRNSAcquisition of global vaccine adjuvant specialist
12th Dec 20181:14 pmRNSDirector/PDMR Shareholding
22nd Nov 20181:54 pmRNSDirector Declaration
22nd Nov 20188:07 amRNSDirector/PDMR Shareholding
14th Nov 20182:48 pmRNSDirector/PDMR Shareholding
14th Nov 20188:24 amRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSTrading Update for the Third Quarter 2018
26th Oct 20187:00 amRNSAcquisition update
12th Oct 20181:42 pmRNSDirector/PDMR Shareholding
4th Oct 20183:03 pmRNSDirector/PDMR Shareholding
4th Oct 20183:01 pmRNSDirector/PDMR Shareholding
28th Sep 20183:35 pmRNSDirector/PDMR Shareholding
11th Sep 20184:50 pmRNSDirector/PDMR Shareholding
6th Sep 20184:07 pmRNSDirector/PDMR Shareholding
5th Sep 20187:00 amRNSAppointment of Broker
22nd Aug 201811:06 amRNSDirector Declaration
13th Aug 20184:37 pmRNSDirector/PDMR Shareholding
7th Aug 20189:11 amRNSDirector/PDMR Shareholding
31st Jul 20184:16 pmRNSDirector/PDMR Shareholding
25th Jul 20184:19 pmRNSDirector/PDMR Shareholding
25th Jul 20187:00 amRNSResults for the six months ended 30 June 2018
11th Jul 20182:27 pmRNSDirector/PDMR Shareholding
21st Jun 20187:00 amRNSDirector/PDMR Shareholding
12th Jun 20184:04 pmRNSDirector/PDMR Shareholding
11th Jun 20182:02 pmRNSDirector/PDMR Shareholding
31st May 20183:41 pmRNSDirector/PDMR Shareholding
25th May 20182:09 pmRNSDirector/PDMR Shareholding
11th May 20184:31 pmRNSDirector/PDMR Shareholding
26th Apr 20183:57 pmRNSDirector/PDMR Shareholding
26th Apr 20189:16 amRNSResult of AGM
25th Apr 20187:00 amRNSTrading Update for the First Quarter 2018
20th Apr 201811:14 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.